-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Geographic distribution of clinical trials may lead to inequities in access
Elizabeth M Seidler, Aparna Keshaviah, Case Brown, Elizabeth Wood, Lisa Granick & Alexandra B Kimball
Research Article: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership
Deborah A Hall,Najibah Mohamad, Lester Firkins, Mark Fenton, David Stockdale(on behalf of the Steering Group)
Research Update: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Brad Spellberg
Brad Spellberg
Interview: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation